Thomas P. Sanderson - Concepedia

Author

Thomas P. Sanderson

Also Known As

T Sanderson, T. P. Sanderson, T. Sanderson, T.P. Sanderson, Thomas P Sanderson, Thomas P. Sanderson, Thomas Paul Sanderson, Thomas Sanderson

Publications

901

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Iowa State University University of Nebraska Medical Center Bristol-Myers Squibb (Germany)The Bristol-Myers Squibb Children's Hospital

About

Thomas P. Sanderson is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	280
2	Education	2	2	31
3	Health Sciences	2	2	36
4	Natural Sciences	1	1	13
5	Public Health	1	1	14

Thomas P. Sanderson

Publications

834

Citations

H-Index

Page 1

	Year	Citations
Metabolic Changes in Blood and Liver During Development and Early Treatment of Experimental Fatty Liver and Ketosis in Cows J.J. Veenhuizen, J.K. Drackley, M. Richard, Journal of Dairy Science	1991	240
Excretion of porcine reproductive and respiratory syndrome virus in semen after experimentally induced infection in boars Sabrina L. Swenson, Howard T. Hill, Jeffrey J. Zimmerman, Journal of the American Veterinary Medical Association	1994	143
Urothelial Carcinogenesis in the Urinary Bladder of Male Rats Treated with Muraglitazar, a PPARα/γ Agonist: Evidence for Urolithiasis as the Inciting Event in the Mode of Action Mark A. Dominick, Melvin R. White, Thomas P. Sanderson, Toxicologic Pathology Molecular PharmacologyUrological ResearchUrologyOncologyChemoprevention Strategy	2006	92
Pharmacodynamics of Selective Inhibition of γ-Secretase by Avagacestat Charles F. Albright, Randy Dockens, Jere E. Meredith, Journal of Pharmacology and Experimental Therapeutics	2012	63
Rodent Carcinogenicity Profile of the Antidiabetic Dual PPAR α and γ Agonist Muraglitazar Sarah H. Tannehill‐Gregg, Thomas P. Sanderson, Daniel J. Minnema, Toxicological Sciences Molecular PharmacologyUrologyOncologyγ Agonist MuraglitazarChemoprevention Strategy	2007	51
Nonclinical Safety Evaluation of Muraglitazar, a Novel PPARα/γ Agonist Crystal R. Waites, Mark A. Dominick, Thomas P. Sanderson, Toxicological Sciences	2007	41
Strain-related Differences in Urine Composition of Male Rats of Potential Relevance to Urolithiasis Sarah H. Tannehill‐Gregg, Mark A. Dominick, Amy J. Reisinger, Toxicologic Pathology	2009	24
Osteopenic Disease in Growing Pigs: Diagnostic Methods Using Serum and Urine Calcium and Phosphorus Values, Parathormone Assay, and Bone Analysis Wayne A. Hagemoser, Jesse P. Goff, Thomas P. Sanderson, Journal of Veterinary Diagnostic Investigation NutritionUrine CalciumOsteoporosisOrthopaedic SurgeryBone Disease	2000	20
Experimental transmission of an apparent viral pneumonia in conventional and gnotobiotic pigs Patrick G. Halbur, P. S. Paul, John J. Andrews, Veterinary Record Endemic PneumoniaElectron MicroscopyImmunologyVeterinary ScienceExperimental Transmission	1993	19
Subchronic Urinary Bladder Effects of Muraglitazar in Male Rats1 Terry R. Van Vleet, Melvin R. White, Thomas P. Sanderson, Toxicological Sciences Urological ResearchUrologyOncologyGenitourinary CancerMedicine	2006	18

Page 1